Related Experiment Video
Updated: Apr 15, 2026

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
[Molecular diagnostics in neuropathology]
W Dietmaier1, J Lorenz, M J Riemenschneider
1Institut für Pathologie, Zentrum für molekularpathologische Diagnostik, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland, Wolfgang.Dietmaier@ukr.de.
Abstract:
As in only few other areas of oncology, molecular markers in neurooncology have become an integral part of clinical decision-making. This development is driven by a bustling scientific activity exploring the molecular basis and pathogenesis of human brain tumors. In addition, a high percentage of brain tumor patients are included in clinical studies in which molecular markers are assessed and linked with clinical informativeness. First steps towards more differentiated therapeutic strategies against brain tumors have thus been taken. The implementation in the clinical and diagnostic routine requires a detailed knowledge and a close collaboration between all medical disciplines involved.
More Related Videos
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Modern Molecular Taxonomy
Applications of Molecular Taxonomy